Workflow
Biomea Fusion(BMEA) - 2023 Q3 - Quarterly Report
BMEABiomea Fusion(BMEA)2023-10-29 16:00

We may be required to protect our patents through procedures created to attack the validity of a patent at the USPTO. The USPTO hears post-grant proceedings, including post grant review (PGR), inter partes review (IPR), and derivation proceedings. An adverse determination in any such submission or proceeding could reduce the scope or enforceability of, or invalidate, our patent rights, which could adversely affect our competitive position. Because of a lower evidentiary standard in USPTO proceedings compare ...